The Best is yet to come – New drugs in Haematology W. Willenbacher editorial 02 July 2009 Pages: 61 - 62
Initiation of the TURANDOT breast cancer study Christoph ZielinskiThomas Brodowicz CECOG News 02 July 2009 Pages: 63 - 63
Pharmacogenomics to improve childhood acute lymphoblastic leukaemia therapy Leo Kager short review 02 July 2009 Pages: 65 - 70
Paediatric NEWS & NOTES from the 50th annual ASH meeting Sabine K. Breuer ASH report 02 July 2009 Pages: 71 - 73
New drugs in the treatment of acute myeloid leukaemia S. KayserRichard F. Schlenk short review 02 July 2009 Pages: 75 - 79
New approaches to the treatment of adult acute lymphoblastic leukaemia Nicola GökbugetB. Wassmann short review 02 July 2009 Pages: 80 - 88
Pathogenetic and clinical impact of JAK2 mutations in chronic myeloproliferative diseases G. WebersinkeHolger Rumpold short review 02 July 2009 Pages: 89 - 93
New treatment options for the management of non-Hodgkin lymphoma S. KassamSilvia Montoto short review 02 July 2009 Pages: 94 - 99
The lymphomas: “Nothing New in the West”? W. WillenbacherE. Willenbacher ASH report – Lymphomas 02 July 2009 Pages: 101 - 102
Acute myeloid leukaemia (AML) and allogeneic haematopoietic stem cell transplantation David Nachbaur ASH report – AML 02 July 2009 Pages: 104 - 107
News from endocrine treatment in breast cancer from the San Antonio Breast Cancer Symposium 2008 Brigitte Mlineritsch San Antonio Report – breast cancer 02 July 2009 Pages: 110 - 112
Bevacizumab-based combination therapy in a patient with pseudomyxoma peritonei W. L. SunG. HutarewMichael Fiegl case report 02 July 2009 Pages: 113 - 115